Commercial Services Healthcare Sector

Aquestive Therapeutics

Market Cap: US$227.5m

Operates as a pharmaceutical company in the United States and internationally.

Tevogen Bio Holdings

Market Cap: US$226.2m

A clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders.

Annexon

Market Cap: US$226.0m

A clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.

Optima Health

Market Cap: UK£166.9m

Provides occupational health and wellbeing services for the public and private sectors in the United Kingdom.

Solid Biosciences

Market Cap: US$224.0m

Develops therapies for neuromuscular and cardiac diseases in the United States.

OptimizeRx

Market Cap: US$223.6m

Operates as a digital healthcare technology company.

ADC Therapeutics

Market Cap: US$221.2m

Provides antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid tumors.

Fennec Pharmaceuticals

Market Cap: US$220.1m

Operates as a commercial stage biopharmaceutical company in the United States.

MediWound

Market Cap: US$219.8m

A biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally.

Design Therapeutics

Market Cap: US$219.7m

A clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States.

enGene Holdings

Market Cap: US$218.7m

Through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer.

Aardvark Therapeutics

Market Cap: US$217.2m

A clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.

Medical Facilities

Market Cap: CA$297.4m

Through its subsidiaries, owns and operates specialty surgical hospitals and ambulatory surgery center in the United States.

Monopar Therapeutics

Market Cap: US$216.6m

A clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.

ProKidney

Market Cap: US$215.7m

A clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States.

Performant Healthcare

Market Cap: US$213.8m

Provides audit, recovery, and analytics services in the United States.

Bright Minds Biosciences

Market Cap: CA$292.9m

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Integrated Diagnostics Holdings

Market Cap: US$211.6m

Operates as a consumer healthcare company that provides medical diagnostics services to patients.

VitaSpring Biomedical

Market Cap: US$207.0m

Focuses on the development of drugs of cell medicine.

Bioventix

Market Cap: UK£151.5m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

Codexis

Market Cap: US$203.8m

Provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.

Tango Therapeutics

Market Cap: US$202.2m

A precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need.

Monash IVF Group

Market Cap: AU$311.7m

Provides assisted reproductive and specialist women imaging services in Australia and Malaysia.

Orthocell

Market Cap: AU$310.9m

A regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia, the United States, the United Kingdom, and the European Union.

BioStem Technologies

Market Cap: US$200.0m

A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.

Actuate Therapeutics

Market Cap: US$198.2m

A clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States.

ME Therapeutics Holdings

Market Cap: CA$268.7m

A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.

4basebio

Market Cap: UK£144.1m

Engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally.

SOPHiA GENETICS

Market Cap: US$193.1m

Operates as a cloud-native software technology company in the healthcare space.

OraSure Technologies

Market Cap: US$191.9m

Develops, manufactures, markets, sells, and distributes diagnostic products, specimen collection devices, and other diagnostic products in the United States, Europe, Africa, and internationally.

Cardiff Oncology

Market Cap: US$191.6m

A clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers.

High Tide

Market Cap: CA$261.4m

Engages in the cannabis retail business in Canada, the United States, and internationally.

CARGO Therapeutics

Market Cap: US$189.1m

A clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients.

Born

Market Cap: US$188.8m

Does not have significant operations.

Omeros

Market Cap: US$188.7m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.

UroGen Pharma

Market Cap: US$188.1m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.